Investors Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,859
Closed -$679K 113
2021
Q4
$679K Sell
8,859
-1,486
-14% -$118K 0.32% 84
2021
Q3
$777K Buy
10,345
+8
+0.1% +$608 0.41% 68
2021
Q2
$804K Sell
10,337
-595
-5% -$44.3K 0.43% 66
2021
Q1
$804K Buy
10,932
+800
+8% +$59K 0.47% 58
2020
Q4
$791K Buy
10,132
+1,552
+18% +$119K 0.52% 55
2020
Q3
$679K Buy
8,580
+1,413
+20% +$111K 0.51% 56
2020
Q2
$529K Buy
7,167
+458
+7% +$34.5K 0.44% 70
2020
Q1
$493K Buy
6,709
+1,198
+22% +$94.2K 0.5% 63
2019
Q4
$478K Buy
+5,511
New +$453K 0.39% 73

Other funds holding MRK

Investors Financial Group's MRK Position: Q1 2022 in Review

Investors Financial Group sold out of Merck (MRK) in Q1 2022, closing a stake of 8,859 shares — an estimated $679K sold.

Investors Financial Group first reported a position in MRK in Q4 2019 and held it in 9 quarters. The position peaked at $804K in Q2 2021. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Investors Financial Group reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 8,859 Merck shares in Q1 2022, an estimated $679K.
  • Investors Financial Group first reported a position in Merck in Q4 2019 and held it in 9 quarters.
  • Investors Financial Group's Merck position peaked at $804K in Q2 2021.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.